Yajko, D M <br/><br/>
In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Dec 1990 
 - 2442-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0066-4804 
<br/><br/><label>Standard No.: </label>10.1128/AAC.34.12.2442  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--complications<br/>Anti-Infective Agents--pharmacology<br/>Ciprofloxacin--pharmacology<br/>Drug Synergism<br/>Ethambutol--pharmacology<br/>Fluoroquinolones<br/>Microbial Sensitivity Tests<br/>Mycobacterium avium Complex--drug effects<br/>Mycobacterium avium-intracellulare Infection--etiology<br/>Rifampin--pharmacology